Two Sigma Advisers’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
225,000
-35,400
| -14% | -$28.7K | ﹤0.01% | 2137 |
|
|
2025
Q1 | $200K | Sell |
260,400
-39,600
| -13% | -$30.4K | ﹤0.01% | 2139 |
|
|
2024
Q4 | $383K | Buy |
300,000
+252,100
| +526% | +$321K | ﹤0.01% | 1879 |
|
|
2024
Q3 | $99.2K | Sell |
47,900
-3,000
| -6% | -$6.21K | ﹤0.01% | 2166 |
|
|
2024
Q2 | $194K | Sell |
50,900
-19,300
| -27% | -$73.5K | ﹤0.01% | 2223 |
|
|
2024
Q1 | $333K | Buy |
70,200
+8,400
| +14% | +$39.8K | ﹤0.01% | 2032 |
|
|
2023
Q4 | $264K | Buy |
61,800
+30,700
| +99% | +$131K | ﹤0.01% | 2148 |
|
|
2023
Q3 | $96.1K | Sell |
31,100
-15,700
| -34% | -$48.5K | ﹤0.01% | 2214 |
|
|
2023
Q2 | $211K | Sell |
46,800
-3,700
| -7% | -$16.7K | ﹤0.01% | 2085 |
|
|
2023
Q1 | $288K | Sell |
50,500
-24,800
| -33% | -$141K | ﹤0.01% | 2153 |
|
|
2022
Q4 | $455K | Sell |
75,300
-34,233
| -31% | -$207K | ﹤0.01% | 1921 |
|
|
2022
Q3 | $724K | Sell |
109,533
-126,167
| -54% | -$834K | ﹤0.01% | 1686 |
|
|
2022
Q2 | $1.23M | Buy |
235,700
+109,200
| +86% | +$570K | ﹤0.01% | 1477 |
|
|
2022
Q1 | $873K | Buy |
126,500
+42,200
| +50% | +$291K | ﹤0.01% | 1704 |
|
|
2021
Q4 | $1.05M | Buy |
+84,300
| New | +$1.05M | ﹤0.01% | 1542 |
|